• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

儿童浆母细胞淋巴瘤伴恶性浆膜腔积液一例并诊断难点分析。

An unusual case of paediatric plasmablastic lymphoma presenting with malignant effusion and the challenges in its diagnosis.

机构信息

Department of Pathology and Lab Medicine, AIIMS, Bhopal, India.

Department of Paediatrics, AIIMS, Bhopal, India.

出版信息

Diagn Cytopathol. 2021 Oct;49(10):E389-E394. doi: 10.1002/dc.24829. Epub 2021 Jul 23.

DOI:10.1002/dc.24829
PMID:34296830
Abstract

Plasmablastic lymphoma (PBL) is an aggressive non-Hodgkin lymphoma occurring commonly in the oral mucosa and jaw of human immunodeficiency virus (HIV) positive adult males. PBL is not a common occurrence in children and a presentation with malignant effusion is rarely reported. Herein, we share our experience in the challenges confronted in the diagnosis of PBL in a 6-year-old, HIV positive boy presenting with malignant pleural and peritoneal effusions along with gum hypertrophy, lymphadenopathy and paranasal sinus mass. Amenability of pleural effusion to exfoliative cytology led to an initial cytological examination demonstrating large atypical lymphoid cells with plasmacytoid morphology and a plasmablastic variant of Burkitt lymphoma was initially considered. However immunophenotyping by flowcytometry (FCM) and a cell block immunohistochemical evaluation of the serous effusion suggested a plasma cell immunophenotype and a diagnosis of PBL was favored. A subsequent biopsy from the paranasal sinus mass confirmed the diagnosis of PBL but showed tumour cell angiocentricity on morphology and CD45 expression on immunohistochemistry (IHC), both unusual features in PBL. A CD20 negative/MUM-1 positive immunoprofile and presence of a solid tumour mass in a typical location in addition to malignant effusion substantiated the diagnosis of PBL. The patient was offered HAART (highly active antiretroviral therapy) and chemotherapy and is on follow-up. Paediatric PBL with malignant effusion is rarely reported and this case stresses the importance of use of a multimodality diagnostic approach for an accurate diagnosis.

摘要

浆母细胞淋巴瘤(PBL)是一种常见于人类免疫缺陷病毒(HIV)阳性成年男性口腔和颌骨的侵袭性非霍奇金淋巴瘤。PBL 在儿童中并不常见,恶性胸腔积液的表现很少见报道。在此,我们分享了我们在诊断一名 6 岁 HIV 阳性男孩的 PBL 时所面临的挑战的经验,该男孩表现为恶性胸腔和腹腔积液,同时伴有牙龈肥大、淋巴结病和副鼻窦肿块。胸腔积液的脱落细胞学检查的可行性导致了最初的细胞学检查显示出具有浆细胞样形态的大型非典型淋巴细胞,最初考虑为伯基特淋巴瘤的浆母细胞变体。然而,流式细胞术(FCM)的免疫表型分析和浆膜积液的细胞块免疫组织化学评估提示浆细胞免疫表型,支持 PBL 的诊断。随后从副鼻窦肿块的活检证实了 PBL 的诊断,但在形态学上显示肿瘤细胞血管中心性和 CD45 在免疫组织化学(IHC)上的表达,这在 PBL 中都是不常见的特征。CD20 阴性/MUM-1 阳性免疫组化和在典型位置存在实体瘤肿块以及恶性胸腔积液证实了 PBL 的诊断。患者接受了高效抗逆转录病毒治疗(HAART)和化疗,并正在接受随访。儿童伴恶性胸腔积液的 PBL 很少见,这个病例强调了使用多模态诊断方法进行准确诊断的重要性。

相似文献

1
An unusual case of paediatric plasmablastic lymphoma presenting with malignant effusion and the challenges in its diagnosis.儿童浆母细胞淋巴瘤伴恶性浆膜腔积液一例并诊断难点分析。
Diagn Cytopathol. 2021 Oct;49(10):E389-E394. doi: 10.1002/dc.24829. Epub 2021 Jul 23.
2
Plasmablastic lymphoma presenting as a large intracardiac mass and bilateral pleural effusions.浆母细胞性淋巴瘤表现为巨大的心内肿块和双侧胸腔积液。
Exp Mol Pathol. 2016 Feb;100(1):79-81. doi: 10.1016/j.yexmp.2015.11.022. Epub 2015 Dec 1.
3
EBV-associated but HHV8-unrelated double-hit effusion-based lymphoma.EB病毒相关但与卡波西肉瘤疱疹病毒无关的基于积液的双打击淋巴瘤。
Diagn Cytopathol. 2017 Mar;45(3):257-261. doi: 10.1002/dc.23638. Epub 2016 Nov 26.
4
From the archives of MD Anderson Cancer Center: Plasmablastic lymphoma presenting as a kidney mass in an immunocompetent patient: Case report and literature review.从 MD 安德森癌症中心档案库:浆母细胞淋巴瘤表现为免疫功能正常患者的肾脏肿块:病例报告和文献复习。
Ann Diagn Pathol. 2023 Dec;67:152186. doi: 10.1016/j.anndiagpath.2023.152186. Epub 2023 Jul 29.
5
Serous effusions in malignant lymphomas: a review.恶性淋巴瘤中的浆液性积液:综述
Diagn Cytopathol. 2006 May;34(5):335-47. doi: 10.1002/dc.20432.
6
Clinicopathologic features of plasmablastic lymphoma: Single-center series of 8 cases from Saudi Arabia.浆母细胞淋巴瘤的临床病理特征:沙特阿拉伯单中心8例系列研究
Diagn Pathol. 2015 Jun 25;10:78. doi: 10.1186/s13000-015-0315-z.
7
Double-hit plasmablastic lymphoma with malignant pleural effusion and leukaemic presentation.伴有恶性胸腔积液和白血病表现的双打击浆母细胞淋巴瘤
Pathology. 2020 Jun;52(4):488-491. doi: 10.1016/j.pathol.2020.03.004. Epub 2020 Apr 27.
8
Plasmablastic lymphoma: An update.弥漫性大 B 细胞淋巴瘤:更新。
Int J Lab Hematol. 2022 Sep;44 Suppl 1(Suppl 1):54-63. doi: 10.1111/ijlh.13863.
9
Unusual presentation of plasmablastic lymphoma involving ovarian mature cystic teratoma: a case report.累及卵巢成熟囊性畸胎瘤的浆母细胞淋巴瘤的罕见表现:一例报告
Diagn Pathol. 2017 Nov 29;12(1):83. doi: 10.1186/s13000-017-0672-x.
10
[Plasmablastic lymphoma].[浆母细胞淋巴瘤]
Med Clin (Barc). 2016 Nov 4;147(9):399-404. doi: 10.1016/j.medcli.2016.06.036. Epub 2016 Aug 28.

引用本文的文献

1
Effusion cytology of EBV-associated lymphoma: a concise review.EB病毒相关淋巴瘤的积液细胞学:简要综述
Blood Res. 2025 Jul 2;60(1):37. doi: 10.1007/s44313-025-00088-0.
2
Frequent association of malignant effusions in plasmablastic lymphoma: a single-institutional experience of nine cases in Taiwan.浆母细胞淋巴瘤中恶性胸腔积液的频繁关联:台湾一家机构9例病例的经验
Blood Res. 2025 Apr 7;60(1):22. doi: 10.1007/s44313-025-00070-w.
3
Sinonasal Plasmablastic Lymphoma: A Systematic Review.鼻窦浆母细胞淋巴瘤:一项系统综述
J Neurol Surg Rep. 2024 Nov 13;85(4):e167-e177. doi: 10.1055/a-2444-3438. eCollection 2024 Oct.
4
An evidence based immunohistochemical panel for diagnosing oral lymphoma along with a case series.用于诊断口腔淋巴瘤的循证免疫组织化学检测组合及病例系列
J Family Med Prim Care. 2024 May;13(5):2143-2148. doi: 10.4103/jfmpc.jfmpc_1570_23. Epub 2024 May 24.
5
Plasmablastic Lymphoma. A State-of-the-Art Review: Part 1-Epidemiology, Pathogenesis, Clinicopathologic Characteristics, Differential Diagnosis, Prognostic Factors, and Special Populations.浆母细胞淋巴瘤。最新综述:第1部分——流行病学、发病机制、临床病理特征、鉴别诊断、预后因素及特殊人群
Mediterr J Hematol Infect Dis. 2024 Jan 1;16(1):e2024007. doi: 10.4084/MJHID.2024.007. eCollection 2024.